Cancer
Pharmacoeconomic Evaluation of CDK4/6 Inhibitors C
Pharmacoeconomic Evaluation of CDK4/6 Inhibitors Combined with Endocrine Therapy in Breast Cancer

The cost-effectiveness of CDK4/6 inhibitors plus endocrine therapy in treating HR+/HER2- breast cancer is evaluated in pharmacoeconomic studies.

Februery 2024

Gastric Cancer Screening: Advancements in Early De
Gastric Cancer Screening: Advancements in Early Detection Strategies

Novel screening approaches, including serum biomarkers and artificial intelligence-assisted endoscopy, show promise for early detection and improved outcomes in gastric cancer.

Februery 2024

Minimally Invasive Surgery Offers Safe Alternative
Minimally Invasive Surgery Offers Safe Alternative for Pancreatic Cancer

Minimally invasive distal pancreatectomy with splenectomy demonstrates safety and efficacy as an alternative to traditional open surgery for early-stage pancreatic cancer.

Februery 2024

Assessing the Carcinogenic Potential of Aspartame:
Assessing the Carcinogenic Potential of Aspartame: Insights from the WHO

The International Agency for Research on Cancer (IARC) concludes that the sweetener aspartame falls under the category of ’possibly carcinogenic,’ maintaining previous safety thresholds.

Februery 2024

Beyond Mammograms: Identifying Women at Higher Ris
Beyond Mammograms: Identifying Women at Higher Risk for Breast Cancer

The study underscores the importance of considering additional risk factors beyond breast density to identify women at higher risk for breast cancer.

Februery 2024

Glaucoma Diagnosis in Highly Myopic Eyes: Clinical
Glaucoma Diagnosis in Highly Myopic Eyes: Clinical Challenge

Diagnosing glaucoma in highly myopic eyes presents clinical challenges due to anatomical variations and visual field changes, necessitating specialized approaches.

January 2024

Hematological Cancer Risk Associated with Undiffer
Hematological Cancer Risk Associated with Undifferentiated Pruritus

Limited diagnostic utility is observed in LDH levels for patients with undifferentiated pruritus, highlighting challenges in identifying hematological cancer risk in these individuals.

January 2024

Identifying Women at Higher Risk for Breast Cancer
Identifying Women at Higher Risk for Breast Cancer Beyond Mammograms

The study emphasizes the importance of considering additional risk factors beyond breast density to identify women at higher risk for breast cancer.

January 2024

New Recommendations on Breast Cancer Screening
New Recommendations on Breast Cancer Screening

Recent updates recommend universal breast cancer screening starting at age 40, signaling a shift in screening guidelines and emphasizing the need for further research in key areas.

January 2024

Sublobar Resection Comparable to Lobectomy for Lun
Sublobar Resection Comparable to Lobectomy for Lung Cancer

Sublobar resection demonstrates noninferiority to lobectomy in terms of disease-free survival for early-stage non-small cell lung cancer, offering a less invasive treatment option.

January 2024